Barricaid annular closure device reduces reherniation rate after discectomy for lumbar herniation .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Annular closure in lumbar microdiscectomy for prevention of reherniation: a randomized clinical trial
Spine J. 2018 Dec;18(12):2278-2287. doi: 10.1016/j.spinee.2018.05.003554 patients with a lumbar disc herniation, large annular defect, and scheduled for lumbar discectomy were randomized to the surgery with or without additional intervention using an annular closure device (Barricaid; Intrinsic Therapeutics). Patients were followed primary for the incidence of re-herniation and composite endpoints of success over the first 2 years after surgery. Results demonstrated a significantly lower rate of subsequent symptomatic lumbar disc re-herniation at the index level among the group treated with the annular closure device. In addition, the ACD group also demonstrated significantly higher rates of success using the primary composite endpoint and modified clinical composite endpoint.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
